Lb Pharmaceuticals Inc · NASDAQ:LBRX
BlackRock, Inc. reported a 6.30% stake in Lb Pharmaceuticals Inc (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 6.30% stake in Lb Pharmaceuticals Inc, 1,796,543 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G/A).
- Stake
- 6.30%
- Shares
- 1,796,543
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.30% | 1,796,543 |
Source
Related
- Lb Pharmaceuticals Inc
- BlackRock, Inc.
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026